Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm-Reference-Cited by-同舟云学术

Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm

Published:2022-10 Issue: Volume:172 Page:108-116
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Stamatis Georgios,Leschber Gunda,Schwarz Birte,Brintrup Diana Lütke,Flossdorf Sarah,Passlick Bernward,Hecker Erich,Kugler Christian,Eichhorn Martin,Krbek Thomas,Eggeling Stephan,Hatz Rudolf,Müller Michael Rolf,Hillinger Sven,Aigner Clemens,Jöckel Karl-Heinz

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference35 articles.

1. European Respiratory Society and European Society of Thoracic Surgeons joint task force on fitness for radical therapy. “ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)”;Brunelli;Eur. Respir. J.,2009

2. Temporal trends in the management of potentially resectable lung cancer;Farjah;Ann. Thorac. Surg.,2008

3. Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension;Okada;Cancer,2003

4. Prognosis for long-term survivors of cancer;Janssen-Heijnen;Ann. Onc.,2007

5. Intentional limited pulmonary resection for peripheral T1N0M0 small – sized lung cancer;Koike;J. Thorac. Cardiovasc. Surg.,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial;The Lancet Respiratory Medicine;2024-02

2. Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma—Takeaways From Modern Randomized Trials;The Annals of Thoracic Surgery;2024-01

3. Survival Benefits of Primary Tumor Surgery in Diverse Cancer Types with Synchronous Bone Metastases: A Retrospective Real-World Analysis Using Propensity Score Matching from a 3P Medicine Perspective;2023-12-13

4. Minimally invasive segmentectomy and lobectomy for peripheral stage IA1–2 non-small-cell lung cancer: a case-matched cohort study from a UK Centre;Interdisciplinary CardioVascular and Thoracic Surgery;2023-12-01

5. Sublobar resection versus lobectomy for stage IA non–small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials;Surgical Oncology;2023-12